Difference between revisions of "Template:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Final thoughts and additional resources/Key guidance documents"

From LIMSWiki
Jump to navigationJump to search
(Updated for August)
Line 1: Line 1:
===4.2 Key guidance documents===
===5.2 Key guidance documents===


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=08 July 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html |title=How to Report COVID-19 Laboratory Data |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 August 2020}}


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=05 June 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=08 July 2020}}


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=02 July 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=11 August 2020}}
 
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 July 2020}}


* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/prelim-eval-criteria-digital-contact-tracing.pdf |title=Preliminary Criteria for the Evaluation of Digital Contact Tracing Tools for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 May 2020}}
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/prelim-eval-criteria-digital-contact-tracing.pdf |title=Preliminary Criteria for the Evaluation of Digital Contact Tracing Tools for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 May 2020}}
Line 15: Line 17:
* {{cite web |url=https://www.paho.org/en/file/61863/download?token=4nO-2lxQ |format=PDF |title=Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection |author=Pan American Health Organization |publisher=Pan American Health Organization |date=30 March 2020}}
* {{cite web |url=https://www.paho.org/en/file/61863/download?token=4nO-2lxQ |format=PDF |title=Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection |author=Pan American Health Organization |publisher=Pan American Health Organization |date=30 March 2020}}


* {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=07 July 2020}}
* {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=16 July 2020}}


* {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date=07 July 2020}}
* {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date=13 August 2020}}


* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) |work=FDA-2020-D-1138 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=May 2020}}
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) |work=FDA-2020-D-1138 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=May 2020}}
Line 25: Line 27:
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) |work=FDA-2020-D-0987-0049 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=15 May 2020}}
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) |work=FDA-2020-D-0987-0049 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=15 May 2020}}


* {{cite web |url=https://apps.who.int/iris/handle/10665/331500 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 19 March 2020 |work=WHO/WPE/GIH/2020.2 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}
* {{cite web |url=https://apps.who.int/iris/handle/10665/332076 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020 |work=WHO/WPE/GIH/2020.3 |author=World Health Organization, et al. |publisher=World Health Organization |date=13 May 2020}}


* {{cite web |url=https://apps.who.int/iris/handle/10665/331501 |title=Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: Interim guidance, 19 March 2020 |work=WHO/COVID-19/laboratory/2020.5 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}
* {{cite web |url=https://apps.who.int/iris/handle/10665/331501 |title=Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: Interim guidance, 19 March 2020 |work=WHO/COVID-19/laboratory/2020.5 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}

Revision as of 18:56, 23 August 2020

5.2 Key guidance documents